TR-HIFU for rectosigmoid deep infiltrating endometriosis :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

TR-HIFU emerges as a viable solution for rectosigmoid deep infiltrating endometriosis

Endometriosis Endometriosis
Endometriosis Endometriosis

What's new?

Transrectal high-intensity focused ultrasound significantly improves quality of life, and gynecologic and digestive symptoms in patients with rectosigmoid deep infiltrating endometriosis.

A prospective French multicentric study (phase I clinical trial) illustrated a noteworthy enhancement in gynecologic, digestive symptoms, and quality of life (QOL) for individuals suffering from rectosigmoid deep infiltrating endometriosis using transrectal high-intensity focused ultrasound (TR-HIFU). Investigators sought to establish the viability of utilizing TR-HIFU for treating endometriosis.

A total of 60 volunteers with rectal involvement participated in the study. Patients completed questionnaires on gynecologic and intestinal symptoms, as well as on quality of life using MOS-SF36 scores before treatment and at one, three, and six months post-treatment. As part of the safety evaluation, preoperative magnetic resonance imaging (MRI) was conducted, and post-intervention MRI was performed on the first day to prove the absence of complications. Additionally, at the six-month mark, both MRI and sonography were utilized to evaluate the progression of the endometrial lesion.

The rectal nodule had a mean volume of 3.0 cc. For seventy percent of the individuals, the procedures were conducted under general anesthesia, with a mean treatment duration of 35 minutes. Fifty-five subjects were discharged on the first day. The overall complication rate was 53%, but only 3.3% of patients (n= 2) experienced a postoperative type 2 complication according to the Clavien classification. No fistula was noted.

Among the 60 people observed at one, three, and six months, a notable enhancement in gynecologic, digestive, and quality of life aspects was evident. Imaging at the six-month mark demonstrated a significant 27% decline in volume. TR-HIFU treatment for rectal endometriosis, as demonstrated by a minimal number of adverse events, remarkably improved gynecologic and digestive symptoms, and the quality of life for patients. Hence, it appears to be a compelling minimally invasive substitute to conventional surgical procedures.

Source:

Ultrasound in Obstetrics & Gynecology

Article:

OC09.01: Transrectal high-intensity focused ultrasound for the management of rectosigmoid deep infiltrating endometriosis: results of phase I clinical trial

Authors:

G. Dubernard et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: